Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : ImmunoGen -- Ignore unavailable to you. Want to Upgrade?

To: RJMC who wrote (3663)	11/5/2000 9:30:12 PM
From: Gary Mohilner	Read Replies (2) \| Respond to of 5665

Bob, I think McCamant's and MTSL have been following IMGN so long they're a little shocked by the speed in which their prediction finally came true. They've been on IMGN's side for years, I don't think they'll abandon us know. I think they're just waiting for something new to raise their numbers substantially. It may be a double standard, but you must remember that because of its rapid accent IMGN is now by far the biggest holding in both of their portfolios, it represents over 20% of each. It would not surprise me if they took profits and lessened their position to balance the portfolios. At the same time, I do believe they'll raise their prices substantially after Dr. Tolchers presentation and the offering. Gary